Sleep Medicine News

Air quality, noise and temperature levels were all associated with decreased sleep efficiency, according to a recent study, although such associations may not be apparent to individuals.

In this edition, trichloroethylene may be ‘invisible’ cause of PD, ravulizumab reduces clinical deterioration in generalized myasthenia gravis and more.

The FDA has granted Noctrix Health its de novo request for the NTX100 Tonic Motor Activation System, the first therapy for patients with moderate to severe, drug-refractory restless legs syndrome, according to a company press release.

After 6 months of treatment, digital cognitive behavioral therapy for insomnia was superior to medication in improving sleep quality, but combining the two has “the potential to optimize outcomes,” according to researchers.

More than 40% of patients with long COVID reported having mild to severe sleep disturbances, with Black individuals and those hospitalized for COVID-19 at greater risk for worsened sleep, a recent study found.

Symptoms of sleep disturbance, including long or short duration, impaired quality and difficulty getting to or maintaining sleep, were significantly associated with increased odds of stroke, according to research presented in Neurology.

Idorsia Pharmaceuticals announced that a citizen petition was filed on its behalf, asking the DEA to de-schedule the dual orexin receptor antagonist class of chronic insomnia medications.

There is currently a lack of research on obstructive sleep apnea in Latin American women, and one researcher plans to change that with a grant from the CHEST Foundation and the American Academy of Sleep Medicine Foundation.

Treatment with pitolisant demonstrated significant efficacy in reducing excessive daytime sleepiness and cataplexy in children aged 6 years and older, according to research presented in The Lancet Neurology.

Left undiagnosed and untreated, obstructive sleep apnea can result in several poor consequences related to health, work and relationships, according to a press release from the American Academy of Sleep Medicine, or AASM.